Switch to:

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Chris Davis 2014-09-30 Reduce -76.1%1.52%$76.11 - $82.24 $ 100.6228%2153905
NWQ Managers 2014-09-30 Reduce -8.48%0.14%$76.11 - $82.24 $ 100.6228%1939169
Joel Greenblatt 2014-09-30 Reduce -85.79%0.05%$76.11 - $82.24 $ 100.6228%9348
Chris Davis 2014-06-30 Reduce -21.19%0.51%$72.58 - $78.92 $ 100.6233%9012151
Scott Black 2014-06-30 Reduce -29.12%0.41%$72.58 - $78.92 $ 100.6233%126558
NWQ Managers 2014-06-30 Reduce -22.79%0.41%$72.58 - $78.92 $ 100.6233%2118767
Tom Gayner 2014-06-30 Add 105.21%0.22%$72.58 - $78.92 $ 100.6233%197000
Joel Greenblatt 2014-06-30 Add 763.24%0.05%$72.58 - $78.92 $ 100.6233%65796
Ken Fisher 2014-06-30 Add 76.33%0.01%$72.58 - $78.92 $ 100.6233%155365
Chris Davis 2014-03-31 Reduce -65.41%3.79%$65.44 - $75.3 $ 100.6242%11435259
Robert Olstein 2014-03-31 New Buy0.94%$65.44 - $75.3 $ 100.6242%92000
PRIMECAP Management 2014-03-31 Add 521.24%0.23%$65.44 - $75.3 $ 100.6242%3221930
Tom Gayner 2014-03-31 New Buy0.22%$65.44 - $75.3 $ 100.6242%96000
NWQ Managers 2014-03-31 Reduce -7.26%0.14%$65.44 - $75.3 $ 100.6242%2744031
Wallace Weitz 2014-03-31 Sold Out 0.02%$65.44 - $75.3 $ 100.6242%0
Ken Fisher 2014-03-31 Reduce -44.33%0.01%$65.44 - $75.3 $ 100.6243%88108
Joel Greenblatt 2014-03-31 Add 77.75%$65.44 - $75.3 $ 100.6242%7622
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on CVS Health Corp

Mario Gabelli Comments on CVS Health Corp - Oct 29, 2014

CVS Health Corp. (1.6%) (CVS - $79.59 - NYSE) operates one of the largest retail pharmacy chains in the country, and the company is poised to benefit from the expansion of insurance coverage under healthcare reform with no new taxes or regulation. CVS is expanding into the fast growing market for specialty and biotech medicines, particularly through the recently announced $2 billion acquisition of home infusion provider Coram. CVS Health recently stopped selling tobacco in its stores, but the company is performing so strongly this year that it can easily absorb the $2 billion in lost sales. The company can sustain double digit earnings growth, and management continues to return a substantial amount of cash to shareholders via a higher dividend and share repurchases.

From Mario Gabelli (Trades, Portfolio)’s Equity Income Fund Q3 2014 Commentary.

Check out Mario Gabelli latest stock trades

Jeff Auxier Comments on CVS - Feb 13, 2014

Healthcare stocks in the Fund had a strong fourth quarter and year. CVS (CVS)’s 26% performance for the quarter is reflective of the fact that 10,000 Americans turn 65 every day and will for the next 15 years. Businesses that are able to serve this growing segment with improving service, innovation, technology, product quality and value should continue to win.



From Jeff Auxier (Trades, Portfolio)'s fourth quarter 2013 commentary.

Check out Jeff Auxier latest stock trades

Top Ranked Articles about CVS Health Corp

Oakmark Equity and Income Fund Fourth Quarter 2014 Commentary
Another strong December, quarter and year Read more...
Mario Gabelli Comments on CVS Health Corp
CVS Health Corp. (1.6%) (CVS - $79.59 - NYSE) operates one of the largest retail pharmacy chains in the country, and the company is poised to benefit from the expansion of insurance coverage under healthcare reform with no new taxes or regulation. CVS is expanding into the fast growing market for specialty and biotech medicines, particularly through the recently announced $2 billion acquisition of home infusion provider Coram. CVS Health recently stopped selling tobacco in its stores, but the company is performing so strongly this year that it can easily absorb the $2 billion in lost sales. The company can sustain double digit earnings growth, and management continues to return a substantial amount of cash to shareholders via a higher dividend and share repurchases. Read more...
The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders
Dear Fellow Shareholders: Read more...
NEW SITE FEATURE: 10-Year Median Scans
GuruFocus has always delievered the most vast offering of equity research tools available on the market. Last year we introduced the All-In-One Guru Screener. It has been met with immensely positive feedback and has quickly become the go-to scanner for sophisticated investors. Read more...
Jeff Auxier Comments on CVS
Healthcare stocks in the Fund had a strong fourth quarter and year. CVS (CVS)’s 26% performance for the quarter is reflective of the fact that 10,000 Americans turn 65 every day and will for the next 15 years. Businesses that are able to serve this growing segment with improving service, innovation, technology, product quality and value should continue to win. Read more...
» More Articles for CVS

Ratios

vs
industry
vs
history
P/E(ttm) 26.00
CVS's P/E(ttm) is ranked higher than
76% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 38.90 vs. CVS: 26.00 )
CVS' s 10-Year P/E(ttm) Range
Min: 10.57   Max: 26.02
Current: 26

10.57
26.02
Forward P/E 16.95
CVS's Forward P/E is ranked higher than
76% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 25.58 vs. CVS: 16.95 )
N/A
PE(NRI) 26.00
CVS's PE(NRI) is ranked higher than
82% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 38.20 vs. CVS: 26.00 )
CVS' s 10-Year PE(NRI) Range
Min: 10.58   Max: 26
Current: 26

10.58
26
P/B 3.04
CVS's P/B is ranked higher than
64% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. CVS: 3.04 )
CVS' s 10-Year P/B Range
Min: 1.01   Max: 3.37
Current: 3.04

1.01
3.37
P/S 0.88
CVS's P/S is ranked higher than
76% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 1.61 vs. CVS: 0.88 )
CVS' s 10-Year P/S Range
Min: 0.39   Max: 0.88
Current: 0.88

0.39
0.88
PFCF 28.50
CVS's PFCF is ranked higher than
69% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 43.95 vs. CVS: 28.50 )
CVS' s 10-Year PFCF Range
Min: 9.1   Max: 208.79
Current: 28.5

9.1
208.79
POCF 19.06
CVS's POCF is ranked higher than
72% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 17.71 vs. CVS: 19.06 )
CVS' s 10-Year POCF Range
Min: 6.73   Max: 35.81
Current: 19.06

6.73
35.81
EV-to-EBIT 14.64
CVS's EV-to-EBIT is ranked higher than
86% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 22.92 vs. CVS: 14.64 )
CVS' s 10-Year EV-to-EBIT Range
Min: 7.6   Max: 20.4
Current: 14.64

7.6
20.4
PEG 2.45
CVS's PEG is ranked higher than
92% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CVS: 2.45 )
CVS' s 10-Year PEG Range
Min: 0.56   Max: 7.32
Current: 2.45

0.56
7.32
Shiller P/E 32.54
CVS's Shiller P/E is ranked higher than
76% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 92.82 vs. CVS: 32.54 )
CVS' s 10-Year Shiller P/E Range
Min: 13.89   Max: 32.84
Current: 32.54

13.89
32.84
Current Ratio 1.39
CVS's Current Ratio is ranked higher than
76% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. CVS: 1.39 )
CVS' s 10-Year Current Ratio Range
Min: 1.05   Max: 2.09
Current: 1.39

1.05
2.09
Quick Ratio 0.75
CVS's Quick Ratio is ranked higher than
60% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. CVS: 0.75 )
CVS' s 10-Year Quick Ratio Range
Min: 0.2   Max: 0.93
Current: 0.75

0.2
0.93
Days Inventory 37.17
CVS's Days Inventory is ranked higher than
76% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 40.60 vs. CVS: 37.17 )
CVS' s 10-Year Days Inventory Range
Min: 37.73   Max: 99.44
Current: 37.17

37.73
99.44
Days Sales Outstanding 29.26
CVS's Days Sales Outstanding is ranked higher than
90% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 49.96 vs. CVS: 29.26 )
CVS' s 10-Year Days Sales Outstanding Range
Min: 10.82   Max: 25.13
Current: 29.26

10.82
25.13

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.17
CVS's Dividend Yield is ranked lower than
63% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.47 vs. CVS: 1.17 )
CVS' s 10-Year Dividend Yield Range
Min: 0.42   Max: 1.47
Current: 1.17

0.42
1.47
Dividend Payout 0.27
CVS's Dividend Payout is ranked higher than
90% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CVS: 0.27 )
CVS' s 10-Year Dividend Payout Range
Min: 0.08   Max: 1.87
Current: 0.27

0.08
1.87
Dividend growth (3y) 37.00
CVS's Dividend growth (3y) is ranked higher than
95% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 9.20 vs. CVS: 37.00 )
CVS' s 10-Year Dividend growth (3y) Range
Min: -33.3   Max: 37
Current: 37

-33.3
37
Yield on cost (5-Year) 4.83
CVS's Yield on cost (5-Year) is ranked higher than
80% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 1.91 vs. CVS: 4.83 )
CVS' s 10-Year Yield on cost (5-Year) Range
Min: 1.69   Max: 5.91
Current: 4.83

1.69
5.91
Share Buyback Rate 3.80
CVS's Share Buyback Rate is ranked higher than
95% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: -1.40 vs. CVS: 3.80 )
CVS' s 10-Year Share Buyback Rate Range
Min: 4.1   Max: -20.4
Current: 3.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 1118.00
CVS's Price/Tangible Book is ranked lower than
53% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 33.10 vs. CVS: 1118.00 )
CVS' s 10-Year Price/Tangible Book Range
Min: 1.69   Max: 1069.43
Current: 1118

1.69
1069.43
Price/DCF (Projected) 1.45
CVS's Price/DCF (Projected) is ranked higher than
74% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 5.60 vs. CVS: 1.45 )
CVS' s 10-Year Price/DCF (Projected) Range
Min: 0.82   Max: 13.56
Current: 1.45

0.82
13.56
Price/Median PS Value 1.47
CVS's Price/Median PS Value is ranked higher than
53% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. CVS: 1.47 )
CVS' s 10-Year Price/Median PS Value Range
Min: 0.45   Max: 2.48
Current: 1.47

0.45
2.48
Price/Peter Lynch Fair Value 2.20
CVS's Price/Peter Lynch Fair Value is ranked higher than
86% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CVS: 2.20 )
CVS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.63   Max: 3.68
Current: 2.2

0.63
3.68
Price/Graham Number 36.32
CVS's Price/Graham Number is ranked higher than
62% of the 327 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CVS: 36.32 )
CVS' s 10-Year Price/Graham Number Range
Min: 1.13   Max: 29.02
Current: 36.32

1.13
29.02
Earnings Yield (Greenblatt) 6.80
CVS's Earnings Yield (Greenblatt) is ranked higher than
81% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. CVS: 6.80 )
CVS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.9   Max: 13.1
Current: 6.8

4.9
13.1
Forward Rate of Return (Yacktman) 14.84
CVS's Forward Rate of Return (Yacktman) is ranked higher than
80% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 13.04 vs. CVS: 14.84 )
CVS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.9   Max: 24.2
Current: 14.84

2.9
24.2

Business Description

Industry: Health Care Providers » Medical Care
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
Traded in other countries:CVS.Germany, CVS.Mexico, CVS.Chile,
CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. The Company is an integrated pharmacy health care provider in the United States. They manage pharmaceutical costs and improve health care outcomes through their pharmacy benefit management ("PBM"), mail order and specialty pharmacy division, CVS Caremark Pharmacy Services; our more than 7,600 CVS/pharmacy, Longs Drugs and Drogaria Onofre retail stores; our retail-based health clinic subsidiary, MinuteClinic; and our online retail pharmacies, CVS.com and Onofre.com.br. They have three segments: Pharmacy Services, Retail Pharmacy and Corporate. The pharmacy services segment provides a full range of PBM services, as described more fully below, to their clients consisting primarily of employers, insurance companies, unions, government employee groups, managed care organizations ("MCOs") and other sponsors of health benefit plans and individuals throughout the United States. They operate four mail service dispensing pharmacies in the United States. They also operate a network of smaller mail service specialty pharmacies. There specialty pharmacies support individuals that require complex and expensive drug therapies. There specialty pharmacies were comprised of 11 specialty mail order pharmacies located throughout the United States that are used for delivery of advanced medications to individuals with chronic or genetic diseases and disorders. Substantially all of these pharmacies have been accredited by the Joint Commission, which is an independent, not-for-profit organization that accredits and certifies more than 20,000 health care organizations and programs in the United States. The retail pharmacy segment included 7,660 retail drugstores, of which 7,603 operated a pharmacy, their online retail pharmacy websites, CVS.com and Onofre.com.br, 17 onsite pharmacy stores and our retail health care clinics. There corporate segment provides management and administrative services to support the overall operations of the company. The corporate Segment consists of certain aspects of our executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. The Company's business is subject to federal and state laws and regulations that govern the purchase, sale and distribution of prescription drugs and related services, including administration and management of prescription drug benefits.
» More Articles for CVS

Headlines

Articles On GuruFocus.com
Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition? Jan 22 2015 
18 Cool Dividend Growth Large Caps For A Hot Market Jan 14 2015 
Weekly Insider Sells Highlight: CVS, MNST, CAG, EVHC Jan 11 2015 
Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand PLC, C Jan 10 2015 
Oakmark Equity and Income Fund Fourth Quarter 2014 Commentary Jan 09 2015 
Gilead Strikes Deal with CVS, Hits Back AbbVie Jan 06 2015 
Why Ballard Power Systems Is a Smart Investment Dec 19 2014 
McKesson's Growth Is Set to Continue in the Long Run Nov 25 2014 
CVS Q3 Report Beats Estimates Nov 06 2014 
Mario Gabelli Comments on CVS Health Corp Oct 29 2014 

More From Other Websites
Final Glance: Drug Benefits companies Jan 23 2015
Final Glance: Drugstore companies Jan 23 2015
Final Glance: Drugstore companies Jan 23 2015
Final Glance: Drug Benefits companies Jan 23 2015
CVS HEALTH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 23 2015
Midday Glance: Drugstore companies Jan 23 2015
Early Glance: Drugstore companies Jan 23 2015
Brian Sozzi Wonders: Should CVS Health Scoop Up Divested Family Dollar/Dollar Tree Stores? Jan 23 2015
Thursday's Market Recap Jan 22 2015
Making Money With Charles Payne: 01/22/15 Jan 22 2015
Greek reforms? It's not clear they ever happened Jan 22 2015
Family Dollar, Dollar Tree Set to Join Ranks of Incredible Shrinking Retailers Jan 22 2015
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales Jan 21 2015
CVS Health (CVS) Stock Is Up Today After Goldman Upgrade Jan 21 2015
Cramer: The 2 Who Forecast Netflix Jan 21 2015
Is Retail in Retreat? Jan 21 2015
Obama Targets Income Gap in Address That Shapes 2016 Election Jan 21 2015
Obama shows 6 companies the love in State of the Union Jan 21 2015
Tuesday's Market Recap Jan 20 2015
Alzheimer's Foundation of America Receives CVS Health Community Grant Jan 20 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK